[
  {
    "ts": null,
    "headline": "Merck’s (MRK) WINREVAIR Shows Strong Results in HYPERION Trial",
    "summary": "Merck & Co., Inc. (NYSE:MRK) is one of the 12 stocks that will make you rich in 10 years. On June 23, the company shared encouraging results from its Phase 3 HYPERION trial. The study tested a drug called WINREVAIR (sotatercept-csrk) against a placebo, both combined with standard treatment, in adults recently diagnosed with pulmonary […]",
    "url": "https://finnhub.io/api/news?id=1f27eabd3cd4dec6e26836a46f8e8434d6a9c7825aaadeffbd0e475c341bb8a9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751103679,
      "headline": "Merck’s (MRK) WINREVAIR Shows Strong Results in HYPERION Trial",
      "id": 135617541,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Merck & Co., Inc. (NYSE:MRK) is one of the 12 stocks that will make you rich in 10 years. On June 23, the company shared encouraging results from its Phase 3 HYPERION trial. The study tested a drug called WINREVAIR (sotatercept-csrk) against a placebo, both combined with standard treatment, in adults recently diagnosed with pulmonary […]",
      "url": "https://finnhub.io/api/news?id=1f27eabd3cd4dec6e26836a46f8e8434d6a9c7825aaadeffbd0e475c341bb8a9"
    }
  },
  {
    "ts": null,
    "headline": "Should You Count on MRK for Steady Passive Income?",
    "summary": "Merck & Co., Inc. (NYSE:MRK) is one of the Best Stocks to Buy for Dividends. Merck & Co., Inc. (NYSE:MRK) is a leading pharmaceutical company, best known for its strong presence in oncology, particularly through Keytruda, the top-selling drug globally. Beyond cancer treatment, the company also produces medications for diabetes, as well as vaccines for […]",
    "url": "https://finnhub.io/api/news?id=e075680e90dc3ef92ad7974668c8d55f7a73b281e5c6688fb63cae72014c32f6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751091342,
      "headline": "Should You Count on MRK for Steady Passive Income?",
      "id": 135617543,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Merck & Co., Inc. (NYSE:MRK) is one of the Best Stocks to Buy for Dividends. Merck & Co., Inc. (NYSE:MRK) is a leading pharmaceutical company, best known for its strong presence in oncology, particularly through Keytruda, the top-selling drug globally. Beyond cancer treatment, the company also produces medications for diabetes, as well as vaccines for […]",
      "url": "https://finnhub.io/api/news?id=e075680e90dc3ef92ad7974668c8d55f7a73b281e5c6688fb63cae72014c32f6"
    }
  }
]